Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Min‐Wen Ku, Maryline Bourgine, Pierre Authié, Jodie Lopez, Kirill Nemirov, Fanny Moncoq, Amandine Noirat, Benjamin Vesin, Fabien Névo, Catherine Blanc, Philippe Souque, Houda Tabbal, Emeline Simon, David Hardy, Marine Le Dudal, Françoise Guinet, Laurence Fiette, Hugo Mouquet, François Anna, Annette Martin, Nicolas Escriou, Laleh Majlessi, Pierre Charneau
Topics & Concepts
BiologyVirologyVaccinationNasal administrationViral vectorVector (molecular biology)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakDiseaseOutbreakInfectious disease (medical specialty)MedicineGeneRecombinant DNAGeneticsPathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing